FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2763878889> ?p ?o ?g. }

• W2763878889 abstract "Joint and connective tissue integrity, comfort and function are paramount to optimal performance in exercise, recreational and occupational activities. The fruit of Terminalia chebula has been used extensively in various traditional health systems for different ailments, with additional preclinical and clinical data demonstrating antioxidant and anti-inflammatory potential. The aim of this study was to evaluate the effects of a standardized aqueous extract of Terminalia chebula fruit (AyuFlex®) dietary supplementation on joint mobility, comfort, and functional capacity in healthy overweight subjects. One-hundred and five (105) overweight, apparently healthy male and female subjects (35–70 years of age) were pre-screened and randomized to one of three groups for 84 days: placebo, AyuFlex1 (250 mg twice daily) or AyuFlex2 (500 mg twice daily) in a randomized, double-blind, placebo-controlled design. A two-week placebo lead-in period was used to improve data quality/validity. All subjects had no knee joint discomfort at rest, but experienced knee joint discomfort only with activity/exercise of at least 30 on 100 mm Visual Analog Scale (VAS). Primary outcome measures included symptoms of joint health and function as measured by modified-Knee Injury & Osteoarthritis Outcomes Score (mKOOS) global & modified-Western Ontario and McMaster Universities Arthritis Index (mWOMAC) subscales (discomfort, stiffness and function). Secondary outcomes included VAS questionnaires on overall/whole-body joint health, low back health, knee mobility, willingness and ability to exercise, 6-min walk test for distance and range of motion (ROM) of pain-free knee flexion/extension. Tertiary outcome measures included inflammatory (high sensitivity C-reactive protein (hsCRP), tumor necrosis factor (TNF)-α) and extracellular matrix (ECM)/Connective Tissue (COMP) biomarkers, and safety (vital signs and blood markers) & tolerability (Adverse Event (AE)/ side effect profiles). Compared to placebo, at day 84 AyuFlex® treatment significantly: 1) improved mKOOS global scores in AyuFlex1 + AyuFlex2 (P = 0.023), and improved total and physical function subscale of mWOMAC relative to baseline, 2) improved VAS scores for Knee Discomfort with activity/exercise in AyuFlex1 + AyuFlex2 (P = 0.001) relative to baseline, 3) improved VAS scores for whole-body joint function in AyuFlex1 + AyuFlex2 (P < 0.029) relative to baseline, 4) improved VAS score for decreased knee joint soreness following leg extension challenge for AyuFlex1 (P = 0.022) and AyuFlex2 (P = 0.043) relative to baseline, 5) improved 6-min walk performance distance covered (P = 0.047) and VAS discomfort (P = 0.026) post-6 min walk in AyuFlex1 + AyuFlex2 relative to baseline, 6) and tended to decrease COMP levels in AyuFlex1 + AyuFLex2 (P = 0.104) relative to baseline. All biomarkers of safety remained within normative limits during the study. Low back health tended to improve in the AyuFlex1 and AyuFlex2 group, but failed to reach significance relative to placebo group. AyuFlex® improved mKOOS global scores, knee joint discomfort with activity/exercise, 6-min walk test distance covered and discomfort post-6 min walk test, overall whole-body joint function, knee soreness following leg extension resistance exercise in a healthy, overweight population, without AE. Differences between 250 mg/BID and 500 mg/BID were non-significant for most of the outcome measures, validating the efficacy of the lower dose. ClinicalTrials.gov identifier NCT02589249 ; October 26, 2015." @default.
• W2763878889 created "2017-10-20" @default.
• W2763878889 creator A5004780258 @default.
• W2763878889 creator A5016100440 @default.
• W2763878889 creator A5022116323 @default.
• W2763878889 creator A5030119121 @default.
• W2763878889 creator A5045969160 @default.
• W2763878889 creator A5056737173 @default.
• W2763878889 creator A5062648435 @default.
• W2763878889 date "2017-10-02" @default.
• W2763878889 modified "2023-10-06" @default.
• W2763878889 title "Effects of dietary supplementation with a standardized aqueous extract of Terminalia chebula fruit (AyuFlex®) on joint mobility, comfort, and functional capacity in healthy overweight subjects: a randomized placebo-controlled clinical trial" @default.
• W2763878889 cites W1270648769 @default.
• W2763878889 cites W1605089619 @default.
• W2763878889 cites W1781662501 @default.
• W2763878889 cites W1807700495 @default.
• W2763878889 cites W1837783893 @default.
• W2763878889 cites W1957937187 @default.
• W2763878889 cites W1979497459 @default.
• W2763878889 cites W1995261139 @default.
• W2763878889 cites W1996113462 @default.
• W2763878889 cites W2002187175 @default.
• W2763878889 cites W2003618393 @default.
• W2763878889 cites W2022025132 @default.
• W2763878889 cites W2034813312 @default.
• W2763878889 cites W2045885953 @default.
• W2763878889 cites W2047065697 @default.
• W2763878889 cites W2047512067 @default.
• W2763878889 cites W2053500472 @default.
• W2763878889 cites W2055521278 @default.
• W2763878889 cites W2056710407 @default.
• W2763878889 cites W2071827130 @default.
• W2763878889 cites W2073166586 @default.
• W2763878889 cites W2073922218 @default.
• W2763878889 cites W2076653261 @default.
• W2763878889 cites W2087627250 @default.
• W2763878889 cites W2103179033 @default.
• W2763878889 cites W2106058443 @default.
• W2763878889 cites W2112106763 @default.
• W2763878889 cites W2114426847 @default.
• W2763878889 cites W2119585389 @default.
• W2763878889 cites W2129304038 @default.
• W2763878889 cites W2133915381 @default.
• W2763878889 cites W2135439493 @default.
• W2763878889 cites W2149895004 @default.
• W2763878889 cites W2156552533 @default.
• W2763878889 cites W2161739351 @default.
• W2763878889 cites W2188804651 @default.
• W2763878889 cites W2257494440 @default.
• W2763878889 cites W2299367339 @default.
• W2763878889 cites W2413750437 @default.
• W2763878889 cites W2432216935 @default.
• W2763878889 cites W2507351387 @default.
• W2763878889 cites W2516485099 @default.
• W2763878889 cites W2530191205 @default.
• W2763878889 cites W57554705 @default.
• W2763878889 doi "https://doi.org/10.1186/s12906-017-1977-8" @default.
• W2763878889 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5625793" @default.
• W2763878889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28969626" @default.
• W2763878889 hasPublicationYear "2017" @default.
• W2763878889 type Work @default.
• W2763878889 sameAs 2763878889 @default.
• W2763878889 citedByCount "17" @default.
• W2763878889 countsByYear W27638788892019 @default.
• W2763878889 countsByYear W27638788892020 @default.
• W2763878889 countsByYear W27638788892021 @default.
• W2763878889 countsByYear W27638788892022 @default.
• W2763878889 countsByYear W27638788892023 @default.
• W2763878889 crossrefType "journal-article" @default.
• W2763878889 hasAuthorship W2763878889A5004780258 @default.
• W2763878889 hasAuthorship W2763878889A5016100440 @default.
• W2763878889 hasAuthorship W2763878889A5022116323 @default.
• W2763878889 hasAuthorship W2763878889A5030119121 @default.
• W2763878889 hasAuthorship W2763878889A5045969160 @default.
• W2763878889 hasAuthorship W2763878889A5056737173 @default.
• W2763878889 hasAuthorship W2763878889A5062648435 @default.
• W2763878889 hasBestOaLocation W27638788891 @default.
• W2763878889 hasConcept C126322002 @default.
• W2763878889 hasConcept C14184104 @default.
• W2763878889 hasConcept C142724271 @default.
• W2763878889 hasConcept C159110408 @default.
• W2763878889 hasConcept C168563851 @default.
• W2763878889 hasConcept C1862650 @default.
• W2763878889 hasConcept C204787440 @default.
• W2763878889 hasConcept C27081682 @default.
• W2763878889 hasConcept C2776164576 @default.
• W2763878889 hasConcept C2779951463 @default.
• W2763878889 hasConcept C2780221984 @default.
• W2763878889 hasConcept C2780586474 @default.
• W2763878889 hasConcept C535046627 @default.
• W2763878889 hasConcept C71924100 @default.
• W2763878889 hasConcept C79544238 @default.
• W2763878889 hasConceptScore W2763878889C126322002 @default.
• W2763878889 hasConceptScore W2763878889C14184104 @default.
• W2763878889 hasConceptScore W2763878889C142724271 @default.
• W2763878889 hasConceptScore W2763878889C159110408 @default.
• W2763878889 hasConceptScore W2763878889C168563851 @default.
• W2763878889 hasConceptScore W2763878889C1862650 @default.
• W2763878889 hasConceptScore W2763878889C204787440 @default.
• W2763878889 hasConceptScore W2763878889C27081682 @default.

• next